Extensive pathological changes of the colon in cystic fibrosis and high-strength pancreatic enzymes.

Suppr

超能文献

作者信息

Knabe N, Zak M, Hansen A, Moesgaard J, Kvist N, Beck B, Damgaard K, Koch C

出版信息

Lancet. 1994 May 14;343(8907):1230. doi: 10.1016/s0140-6736(94)92443-0.

DOI:10.1016/s0140-6736(94)92443-0

PMID:7909898

Abstract

摘要

相似文献

Extensive pathological changes of the colon in cystic fibrosis and high-strength pancreatic enzymes.

Lancet. 1994 May 14;343(8907):1230. doi: 10.1016/s0140-6736(94)92443-0.

Pancolonic disease in cystic fibrosis and high-dose pancreatic enzyme therapy.

J Pediatr. 1994 Oct;125(4):587-9. doi: 10.1016/s0022-3476(94)70014-1.

Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes.

Lancet. 1994 Jan 8;343(8889):85-6. doi: 10.1016/s0140-6736(94)90817-6.

High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.

N Engl J Med. 1997 May 1;336(18):1283-9. doi: 10.1056/NEJM199705013361803.

Ulcerative type of colitis associated with the use of high strength pancreatic enzyme supplements in cystic fibrosis.

Pediatr Radiol. 1995;25(2):113-5; discussion 115-6. doi: 10.1007/BF02010320.

Fibrosing colonopathy in children with cystic fibrosis.

Postgrad Med J. 1996 Mar;72(845):129-30. doi: 10.1136/pgmj.72.845.129.

Progressive pan-colonic fibrosis secondary to oral administration of pancreatic enzymes.

Pediatr Surg Int. 1998 Mar;13(2-3):168-70. doi: 10.1007/s003830050278.

Concern about records of fibrosing colonopathy study.

Lancet. 2001 May 12;357(9267):1527. doi: 10.1016/S0140-6736(00)04676-6.

Concern about records of fibrosing colonopathy study.

Lancet. 2001 May 12;357(9267):1526-7. doi: 10.1016/s0140-6736(00)04674-2.

Pancreatic enzymes and fibrosing colonopathy.

Lancet. 1999 Jul 17;354(9174):251. doi: 10.1016/s0140-6736(05)66316-7.

引用本文的文献

Cystic fibrosis colonopathy.

Curr Gastroenterol Rep. 1999 Jun;1(3):231-7. doi: 10.1007/s11894-999-0040-4.

Update on intestinal strictures.

J R Soc Med. 1999;92 Suppl 37(Suppl 37):41-9. doi: 10.1177/014107689909237S08.

Subclinical colonic thickening.

J R Soc Med. 1996;89 Suppl 27(Suppl 27):24-30.

Adverse drug events related to dosage forms and delivery systems.

Drug Saf. 1996 Jan;14(1):39-67. doi: 10.2165/00002018-199614010-00005.

Fibrosing colonopathy in cystic fibrosis.

Arch Dis Child. 1996 May;74(5):464-8. doi: 10.1136/adc.74.5.464.

Calcium-activated chloride conductance is not increased in pancreatic duct cells of CF mice.

Pflugers Arch. 1995 May;430(1):26-33. doi: 10.1007/BF00373836.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Extensive pathological changes of the colon in cystic fibrosis and high-strength pancreatic enzymes.

Lancet. 1994 May 14;343(8907):1230. doi: 10.1016/s0140-6736(94)92443-0.

Pancolonic disease in cystic fibrosis and high-dose pancreatic enzyme therapy.

J Pediatr. 1994 Oct;125(4):587-9. doi: 10.1016/s0022-3476(94)70014-1.

Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes.

Lancet. 1994 Jan 8;343(8889):85-6. doi: 10.1016/s0140-6736(94)90817-6.

High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.

N Engl J Med. 1997 May 1;336(18):1283-9. doi: 10.1056/NEJM199705013361803.

Ulcerative type of colitis associated with the use of high strength pancreatic enzyme supplements in cystic fibrosis.

Pediatr Radiol. 1995;25(2):113-5; discussion 115-6. doi: 10.1007/BF02010320.

Fibrosing colonopathy in children with cystic fibrosis.

Postgrad Med J. 1996 Mar;72(845):129-30. doi: 10.1136/pgmj.72.845.129.

Progressive pan-colonic fibrosis secondary to oral administration of pancreatic enzymes.

Pediatr Surg Int. 1998 Mar;13(2-3):168-70. doi: 10.1007/s003830050278.

Concern about records of fibrosing colonopathy study.

Lancet. 2001 May 12;357(9267):1527. doi: 10.1016/S0140-6736(00)04676-6.

Concern about records of fibrosing colonopathy study.

Lancet. 2001 May 12;357(9267):1526-7. doi: 10.1016/s0140-6736(00)04674-2.

Pancreatic enzymes and fibrosing colonopathy.

Lancet. 1999 Jul 17;354(9174):251. doi: 10.1016/s0140-6736(05)66316-7.

引用本文的文献

Cystic fibrosis colonopathy.

Curr Gastroenterol Rep. 1999 Jun;1(3):231-7. doi: 10.1007/s11894-999-0040-4.

Update on intestinal strictures.

J R Soc Med. 1999;92 Suppl 37(Suppl 37):41-9. doi: 10.1177/014107689909237S08.

Subclinical colonic thickening.

J R Soc Med. 1996;89 Suppl 27(Suppl 27):24-30.

Adverse drug events related to dosage forms and delivery systems.

Drug Saf. 1996 Jan;14(1):39-67. doi: 10.2165/00002018-199614010-00005.

Fibrosing colonopathy in cystic fibrosis.

Arch Dis Child. 1996 May;74(5):464-8. doi: 10.1136/adc.74.5.464.

Calcium-activated chloride conductance is not increased in pancreatic duct cells of CF mice.

Pflugers Arch. 1995 May;430(1):26-33. doi: 10.1007/BF00373836.